Ayman Soubra, MD
Urology · Minneapolis, MNNPI 1689053993
Payments from drug & device makers
Across 266 payments — averaging $768.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Endo Pharmaceuticals Inc.$143K
- Boston Scientific$54K
- Coloplast$3K
- Endo USA, Inc.$847
- Sumitomo Pharma America, Inc.$439
- Teleflex LLC$389
- plus $3K from 36 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$204,395 in reported general payments places this provider in the 95th percentile of 247 urology providers in Minnesota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other urology in Minneapolis
- Badrinath KonetyMinneapolis$230K
- Sean ElliottMinneapolis$192K
- Nissrine NakibMinneapolis$106K
- Travis PagliaraMinneapolis$53K
- Christopher WeightMinneapolis$16K
- James AndersonMinneapolis$5K
- Paras ShahRochester$1.4M
- Joseph ZabellEdina$565K
- Derek LomasRochester$383K
- Steven BernsteinEdina$321K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.